Sage Therapeutics Cash Flow | StatInvestor

Health Care & Life Sciences » Pharmaceuticals | Sage Therapeutics Inc.

Sage Therapeutics Inc. | Cash Flow

No data

About Sage Therapeutics

View Profile

Address	215 First Street Cambridge Massachusetts 02142 United States
Employees	-
Website	http://www.sagerx.com
Updated	07/08/2019
SAGE Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel medicines to treat life-altering central nervous system. Its programs include brexanolone, which is an acute interventional treatment for postpartum depression; and SAGE-217, an oral therapy for treatment of various CNS disorders. The company was founded by Steven Marc Paul and Douglas Covey in April 2010 and is headquartered in Cambridge, MA.